Biosimilar Q&A: Is an interchangeability designation still relevant?
Heidi Hunter, former President of Cardinal Health Specialty Solutions discusses trends influencing the use and reimbursement of biosimilars.
Heidi Hunter, former President of Cardinal Health Specialty Solutions discusses trends influencing the use and reimbursement of biosimilars.